Welcome to CDC stacks | Immunogenicity and safety of GSK’s FluLaval™ quadrivalent inactivated influenza vaccine in children 6-35 months of age - 60664 | Advisory Committee on Immunization Practices (ACIP)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Immunogenicity and safety of GSK’s FluLaval™ quadrivalent inactivated influenza vaccine in children 6-35 months of age
Filetype[PDF-541.10 KB]


Details:
  • Supporting Files:
    No Additional Files
You May Also Like: